Transforming drug discovery with human organ models
CN Bio (cn-bio.com) scores 79 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, Technology brands, in the 68th percentile of 16750 Healthcare brands.
CN Bio is a UK-based company, founded in 2009 and headquartered in Welwyn Garden City, that develops organ-on-a-chip technology for drug discovery. Its PhysioMimix platform provides predictive human organ models and assays, including hardware and consumables, designed to generate human-relevant efficacy, ADME, and safety data. The company positions itself as a world leader in this field, serving pharmaceutical and biotech researchers seeking alternatives to traditional animal testing methods in preclinical drug development.
| Brand Name | CN Bio |
|---|---|
| Domain | cn-bio.com |
| Industry | Healthcare, Technology |
| Founded | 2009 |
| Headquarters | Welwyn Garden City, United Kingdom |
| Main Competitors | Emulate, Mimetas (82/100), TissUse (77/100), Hesperos (56/100), AlveoliX (74/100), Nortis Bio, InSphero (77/100) |
Moz Domain Authority 37/100 vs category average 40 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
Ranked #4,024,640 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "CN Bio is a world leading Organ-on-a-chip company. We empower you to transform drug discovery with PhysioMimix Core predictive human organ models and assays" (Meta description: 24 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Organization schema, Breadcrumb/Website schema, + Microdata, og:title, og:description, og:image, og:type, Twitter cards, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Cloudflare, WordPress, Ghost.
Social footprint: verified profiles on LinkedIn, X (Twitter), Facebook, Instagram, YouTube; no detected presence on GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is CN Bio?", Claude could identify the brand as of October 2026. CN Bio is a biotechnology company that develops organ-on-a-chip (microphysiological) systems, offering platforms like the PhysioMimix that model human liver, lung, and other organ tissue to support drug discovery and toxicology testing as alternatives to animal models. Best known for Organ-on-a-chip microphysiological systems for drug discovery, particularly liver models.
When asked "Best brands similar to CN Bio?", Claude would recommend CN Bio as of October 2026. It's a recognized player in the organ-on-a-chip space alongside companies like Emulate and Mimetas, so it would come up in a discussion of best brands in that niche.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
CN Bio's main competitors in Healthcare: Mimetas (82/100), TissUse (77/100), Hesperos (56/100), AlveoliX (74/100), InSphero (77/100).
Sources: Brand Analyzer scan
CN Bio has limited AI-search visibility, scoring 40/100 on Brand Analyzer's AI visibility composite (visibility 21, trust 54, recommendation 56). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: CN Bio official site
CN Bio was founded in 2009. CN Bio operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
CN Bio offers the PhysioMimix platform, which includes organ-on-a-chip hardware, consumables, and assay solutions. These products are designed to recreate complex human biology on microfluidic chips, enabling researchers to generate human-specific efficacy, ADME, and safety data for drug discovery applications.
Sources: CN Bio official site
CN Bio scores 56/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: CN Bio official site
CN Bio is a UK-based organ-on-a-chip company founded in 2009 and headquartered in Welwyn Garden City, United Kingdom. It specializes in developing predictive human organ models and assays used in drug discovery research.
Sources: CN Bio official site
CN Bio develops and provides organ-on-a-chip technology, including its PhysioMimix platform, which recreates human organ biology on microfluidic chips. This technology generates human-specific efficacy, ADME (absorption, distribution, metabolism, excretion), and safety data intended to more accurately predict human drug responses than traditional preclinical testing methods, such as animal models.
Sources: CN Bio official site
CN Bio can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: CN Bio official site
CN Bio is known for its PhysioMimix organ-on-a-chip platform, which is used by pharmaceutical and biotech researchers to generate predictive human biological data for drug discovery. The company positions itself as a world-leading provider in the organ-on-a-chip sector, offering hardware, consumables, and assay solutions as alternatives to traditional animal testing.
Sources: CN Bio official site
CN Bio's products are used by pharmaceutical and biotech researchers, drug discovery scientists, and organizations seeking predictive, human-relevant preclinical testing solutions as alternatives or supplements to traditional animal testing methods.
Sources: CN Bio official site
CN Bio scores 40/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
CN Bio has a limited AI-visibility profile at 40/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (56/100) and its weakest is visibility (21/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #4,024,640 (Tranco) and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data and a low Moz Domain Authority of 37/100. In a live check, Claude could already identify CN Bio from memory (October 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to CN Bio: Canadian Medical Association (CMA) (79/100), CloudLIMS (79/100), CNIB (79/100), College of Nurses of Ontario (CNO) (79/100).
A step up - brands to learn from: Zymo Research (81/100), Zurich Insurance Group (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.